Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19

Lancet Microbe. 2021 Apr;2(4):e138. doi: 10.1016/S2666-5247(21)00030-6. Epub 2021 Mar 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Blood Component Transfusion
  • COVID-19 Serotherapy
  • COVID-19* / therapy
  • Humans
  • Immunization, Passive
  • Immunocompromised Host
  • Plasma